• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:QTZM)

3.000 UNCHANGED
Streaming Delayed Price Updated: 3:45 PM EST, Jan 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about QTZM

< Previous 1 2 Next >
News headline image
Quantumzyme Corp. Provides 2025 Corporate Update and Outlines Strategic Priorities for 2026
January 26, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence Intellectual Property
Quantumzyme Corp. Provides 2025 Corporate Update and Outlines Strategic Priorities for 2026
January 26, 2026
Via TheNewswire.com
Topics Artificial Intelligence Intellectual Property
Quantumzyme Corp. Announces Memorandum of Understanding With Predictive Research Inc. to Explore AI-Enabled Applications in Green Chemistry and Biocatalysis
January 16, 2026
Via TheNewswire.com
Topics Artificial Intelligence
Quantumzyme Corp. Announces Memorandum of Understanding With Predictive Research Inc. to Explore AI-Enabled Applications in Green Chemistry and Biocatalysis
January 16, 2026
Via NewMediaWire
Topics Artificial Intelligence
News headline image
Quantumzyme to Engage With Industry Leaders at BioLogic Summit 2026, Reinforcing Commitment to AI-Driven Innovation
December 04, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence
Quantumzyme to Engage With Industry Leaders at BioLogic Summit 2026, Reinforcing Commitment to AI-Driven Innovation
December 04, 2025
Via TheNewswire.com
Topics Artificial Intelligence
News headline image
Quantumzyme Announces Board Approval for Strategic Name Change to Quantum Genesis AI
December 01, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence
Quantumzyme Announces Board Approval for Strategic Name Change to Quantum Genesis AI
December 01, 2025
Via TheNewswire.com
Topics Artificial Intelligence
News headline image
Quantumzyme to Showcase Sustainable Enzyme Engineering Innovations at CCE-2026
November 19, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Quantumzyme to Showcase Sustainable Enzyme Engineering Innovations at CCE-2026
November 19, 2025
Via TheNewswire.com
News headline image
Quantumzyme Announces First Lab-Scale Sample of Green Ibuprofen Shipped for Industrial Validation
November 14, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
Quantumzyme Announces First Lab-Scale Sample of Green Ibuprofen Shipped for Industrial Validation
November 14, 2025
Via TheNewswire.com
Topics Intellectual Property
News headline image
Quantumzyme Expands AI-Driven Enzyme Engineering Platform to Broaden Green API Manufacturing Applications
November 11, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Economy Emissions
Quantumzyme Expands AI-Driven Enzyme Engineering Platform to Broaden Green API Manufacturing Applications
November 11, 2025
Via TheNewswire.com
Topics Economy Emissions
News headline image
Quantumzyme Announces Publication of Green Ibuprofen Process in RSC Sustainability
November 05, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Quantumzyme Announces Publication of Green Ibuprofen Process in RSC Sustainability
November 05, 2025
Via TheNewswire.com
Quantumzyme Announces Publication of Patents Supporting Sustainable Pharmaceutical Growth &amp; Innovation
October 31, 2025
Via TheNewswire.com
Topics Intellectual Property
News headline image
Quantumzyme Announces Publication of Patents Supporting Sustainable Pharmaceutical Growth & Innovation
October 31, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
News headline image
Quantumzyme Corp. Participated in Enzyme Engineering XXVIII Conference in Denmark
October 28, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence Intellectual Property
Quantumzyme Corp. Participated in Enzyme Engineering XXVIII Conference in Denmark
October 28, 2025
Via TheNewswire.com
Topics Artificial Intelligence Intellectual Property
News headline image
Quantumzyme Corp. Announces USPTO Publication of Breakthrough Ibuprofen Patent
September 24, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
Quantumzyme Corp. Announces USPTO Publication of Breakthrough Ibuprofen Patent
September 24, 2025
Via TheNewswire.com
Topics Intellectual Property
Quantumzyme Announces Removal of OTC Markets Caveat Emptor Designation
July 24, 2025
Via TheNewswire.com
News headline image
Quantumzyme Announces Removal of OTC Markets Caveat Emptor Designation
July 24, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Quantumzyme Responds to OTC Markets Caveat Emptor Designation and Denounces Unauthorized Promotion Activity
April 30, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Quantumzyme Responds to OTC Markets Caveat Emptor Designation and Denounces Unauthorized Promotion Activity
April 30, 2025
SAN DIEGO, CA - April 30, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, today announced that it is in contact with OTC... 
Via TheNewswire.com
News headline image
Quantumzyme Highlights Benefits and Commercialization Opportunities of Pending Breakthrough Green Chemistry Patent
April 28, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence Intellectual Property
Quantumzyme Highlights Benefits and Commercialization Opportunities of Pending Breakthrough Green Chemistry Patent
April 28, 2025
SAN DIEGO, CA - April 28, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is pleased to announce the key benefits and... 
Via TheNewswire.com
Topics Artificial Intelligence Intellectual Property
News headline image
Quantumzyme Anticipates Publication of Transformative Patent for Enzymatic Ibuprofen Manufacturing
April 23, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
Quantumzyme Anticipates Publication of Transformative Patent for Enzymatic Ibuprofen Manufacturing
April 23, 2025
SAN DIEGO, CA - April 23, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is pleased to announce the upcoming publication of... 
Via TheNewswire.com
Topics Intellectual Property
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap